HTFL HTFL Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax

Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax at other companies

MedtronicMDT

——

Edwards LifesciencesEW

——

Other financials

Income statement

See full

Revenue$52.6M+41.3%

Gross profit$42.2M+50.9%

Operating income-$29.5M-68.6%

Net income-$27.4M+15.4%

EPS (diluted)-$0.32+93.9%

Balance sheet

See full

Cash & equivalents$24.4M-78.7%

Total debt$26.3M—

Total equity$285.7M+132%

Total assets$344.0M—

Cash flow

See full

Operating cash flow-$30.1M-129%

CapEx$1.9M+71.6%

Free cash flow-$32.0M-124%

Valuation

See full

Market cap$2.97B—

Enterprise value$2.98B—

P/S15.5×—

Profitability

See full

Gross margin78.1%+2.4pp

Operating margin-39.7%-4.8pp

Net margin-58.4%-12.1pp

FCF margin-40.1%-2.4pp

Returns & leverage

See full

Return on equity37.1%—

Debt / equity0.1×—

Current ratio5.6×—

Where this comes from

Reported directly by HTFL in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.

The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about HTFL's debt securities, available-for-sale, accumulated gross unrealized loss, before tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HTFL's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?: HTFL (HTFL) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax of $365K in Q1 2026.